CHOP Investigator and Experimental One-dose Gene Therapy for Hemophilia B Featured in The New York Times

A breakthrough research at Children's Hospital of Philadelphia (CHOP) helps scientists edge closer to defeating a longtime enemy of human health: hemophilia, the inability to form blood clots.

Learn more in this article from The New York Times.